CM326 dose 1 + CM326 dose 2 for pulmonary disease, chronic obstructive

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Dec 2025: Trial started, NCT07418736
  2. 18 Feb 2026: Trial registered, NCT07418736

The trials

NCT07418736: A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease

State
Under way
Phase
Phase 2
People
318 planned
Started
18 Dec 2025
Primary completion
1 Jul 2027
Arms
CM326
Results
None posted
  1. 18 Dec 2025: Trial started
  2. 18 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.